Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin
Copyright © 2019 Elsevier Masson SAS. All rights reserved..
Proteasome deregulation has been related with several human diseases and, consequently, a detailed knowledge of its inhibition is essential for the design of efficient and selective drugs. The present paper is focused on the inhibition mechanism of proteasome 20S on the β5-subunit by dihydroeponemycin, an epoxyketone. The presence of a dual electrophilic center in this α,β-epoxyketone allows its irreversible bind to the active site by formation of two strong covalent bonds with the N-terminal threonine residue. Free energy surfaces for all possible mechanisms have been generated in terms of potentials of mean force (PMFs) within hybrid QM/MM potentials, with the QM subset of atoms described at semiempirical (AM1) and DFT (M06-2X) level. Two alternative reaction pathways, differentiated by reversing the order of chemical steps in full catalytic process and the product species, were explored. The resulting activation free energy barriers (ΔG‡) indicate that the most favourable mechanism is the one in which the reaction starts with epoxide-ring opening and finishing with 1,4-oxazepane product formation. This result is in agreement with the seven-membered product of inhibition recently determined by X-ray crystallography. Finally, calculations of primary kinetic isotope effects (1º-KIEs) on Cα and Cβ of epoxide and secondary 2º-KIE on C1 reveal their possible application in distinguishing between the formation of six- and seven-membered product and verifying the reaction mechanism proposed in the present work.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:164 |
|---|---|
| Enthalten in: |
European journal of medicinal chemistry - 164(2019) vom: 15. Feb., Seite 399-407 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Serrano-Aparicio, Natalia [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 06.03.2019 Date Revised 06.03.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejmech.2018.12.062 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM292405650 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM292405650 | ||
| 003 | DE-627 | ||
| 005 | 20231225073030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejmech.2018.12.062 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0974.xml |
| 035 | |a (DE-627)NLM292405650 | ||
| 035 | |a (NLM)30611981 | ||
| 035 | |a (PII)S0223-5234(18)31108-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Serrano-Aparicio, Natalia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.03.2019 | ||
| 500 | |a Date Revised 06.03.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Proteasome deregulation has been related with several human diseases and, consequently, a detailed knowledge of its inhibition is essential for the design of efficient and selective drugs. The present paper is focused on the inhibition mechanism of proteasome 20S on the β5-subunit by dihydroeponemycin, an epoxyketone. The presence of a dual electrophilic center in this α,β-epoxyketone allows its irreversible bind to the active site by formation of two strong covalent bonds with the N-terminal threonine residue. Free energy surfaces for all possible mechanisms have been generated in terms of potentials of mean force (PMFs) within hybrid QM/MM potentials, with the QM subset of atoms described at semiempirical (AM1) and DFT (M06-2X) level. Two alternative reaction pathways, differentiated by reversing the order of chemical steps in full catalytic process and the product species, were explored. The resulting activation free energy barriers (ΔG‡) indicate that the most favourable mechanism is the one in which the reaction starts with epoxide-ring opening and finishing with 1,4-oxazepane product formation. This result is in agreement with the seven-membered product of inhibition recently determined by X-ray crystallography. Finally, calculations of primary kinetic isotope effects (1º-KIEs) on Cα and Cβ of epoxide and secondary 2º-KIE on C1 reveal their possible application in distinguishing between the formation of six- and seven-membered product and verifying the reaction mechanism proposed in the present work | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 1,4-Oxazepane | |
| 650 | 4 | |a Dihydroeponemycin | |
| 650 | 4 | |a Epoxyketones | |
| 650 | 4 | |a Free energy surfaces | |
| 650 | 4 | |a Inhibition mechanism | |
| 650 | 4 | |a Kinetic isotope effects | |
| 650 | 4 | |a Molecular dynamics | |
| 650 | 4 | |a Proteasome 20S | |
| 650 | 4 | |a QM/MM | |
| 650 | 7 | |a Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Protein Subunits |2 NLM | |
| 650 | 7 | |a dihydroeponemycin |2 NLM | |
| 650 | 7 | |a Serine |2 NLM | |
| 650 | 7 | |a 452VLY9402 |2 NLM | |
| 650 | 7 | |a Proteasome Endopeptidase Complex |2 NLM | |
| 650 | 7 | |a EC 3.4.25.1 |2 NLM | |
| 700 | 1 | |a Świderek, Katarzyna |e verfasserin |4 aut | |
| 700 | 1 | |a Moliner, Vicent |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of medicinal chemistry |d 1994 |g 164(2019) vom: 15. Feb., Seite 399-407 |w (DE-627)NLM106608835 |x 1768-3254 |7 nnns |
| 773 | 1 | 8 | |g volume:164 |g year:2019 |g day:15 |g month:02 |g pages:399-407 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejmech.2018.12.062 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 164 |j 2019 |b 15 |c 02 |h 399-407 | ||